Source: International Congress 2016 – New therapies and therapeutic targets
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Rachel Dancer (Banbury, United Kingdom), Rachel Dancer, Dhruv Parekh, David Thickett. LSC Abstract – Effects of vitamin D supplementation on perioperative markers of inflammation in patients at risk of acute respiratory distress syndrome (ARDS). Eur Respir J 2016; 48: Suppl. 60, 466

Member's Comments

No comment yet.

Related content which might interest you: Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD? Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome (ARDS): A retrospective cohort study Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Time course of serum leptin and markers of systemic inflammation during acute hypercapnic respiratory failure in patients with COPD and obesity-hypoventilation syndrome (OHS) Source: Eur Respir J 2006; 28: Suppl. 50, 394s Year: 2006 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Corticosteroids and acute respiratory distress syndrome (ARDS) Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021 KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Source: Eur Respir J 2004; 23: 142-145 Year: 2004 COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002 Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002 The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study Source: International Congress 2016 – Diagnostic and therapeutic challenges in acute respiratory failure Year: 2016 The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Long term effects of prone position in acute respiratory distress syndrome (ARDS) Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Clinico-pathological analysis of acute respiratory distress syndrome (ARDS) Source: Annual Congress 2012 - Multidisciplinary critical care Year: 2012 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Combined cell therapy and anticoagulants for acute respiratory distress syndrome Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 An animal model of the acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 486s Year: 2002